Cargando…

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease

Alzheimer's disease (AD) is a complex neurodegenerative disease characterized by cognitive dysfunction. Kai-Xin-San (KXS) is a traditional Chinese medicine (TCM) formula that has been used to treat AD patients for over a thousand years in China. However, the therapeutic mechanisms of KXS for tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yunxia, Li, Dongli, Liao, Yanfang, Cai, Chuipu, Wu, Qihui, Ke, Hanzhong, Liu, Xinning, Li, Huilin, Hong, Honghai, Xu, Yumin, Wang, Qi, Fang, Jiansong, Fang, Shuhuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147119/ https://www.ncbi.nlm.nih.gov/pubmed/32317964 http://dx.doi.org/10.3389/fphar.2020.00381

Ejemplares similares

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
por: Wu, Qihui, et al.
Publicado: (2020)

Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
por: Xu, Yu-Min, et al.
Publicado: (2019)

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
por: Yi, Pengji, et al.
Publicado: (2020)

Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats
por: Dong, X.Z., et al.
Publicado: (2017)

Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology
por: Guo, Sirui, et al.
Publicado: (2019)

Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
por: Jiao, Ya-Nan, et al.
Publicado: (2022)

Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
por: Su, ShiJie, et al.
Publicado: (2023)

Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway
por: Guo, Sirui, et al.
Publicado: (2019)

Behavioral and biochemical effects of a formulation of the traditional Chinese medicine, Kai-Xin-San, in fatigued rats
por: HU, YUAN, et al.
Publicado: (2013)

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective
por: Wu, Qihui, et al.
Publicado: (2020)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Kai-Xin-San, a Chinese Herbal Decoction, Accelerates the Degradation of β-Amyloid by Enhancing the Expression of Neprilysin in Rats
por: Wang, Na, et al.
Publicado: (2020)

Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD
por: Hong, Honghai, et al.
Publicado: (2020)

Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress
por: Bai, Guiqin, et al.
Publicado: (2022)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
por: Guo, Pengfei, et al.
Publicado: (2019)

Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
por: Wang, Na, et al.
Publicado: (2017)

Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ(1-42) Induced Cognitive Deficit Mice
por: Zhu, Yue, et al.
Publicado: (2019)

Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells
por: Qu, Suchen, et al.
Publicado: (2021)

Identification of protein targets for the antidepressant effects of Kai-Xin-San in Chinese medicine using isobaric tags for relative and absolute quantitation
por: Dong, Xian-Zhe, et al.
Publicado: (2019)

MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1
por: Chen, Chao, et al.
Publicado: (2023)

A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS
por: Yang, Lin, et al.
Publicado: (2022)

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine
por: Wu, Qihui, et al.
Publicado: (2019)

Rapid HPLC Quantification Approach for Detection of Active Constituents in Modern Combinatorial Formula, San-Huang-Xie-Xin-Tang (SHXXT)
por: Wu, Tung-Ying, et al.
Publicado: (2016)

TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology
por: Liu, Zhihong, et al.
Publicado: (2020)

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery
por: Cai, Chuipu, et al.
Publicado: (2023)

Kai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathways
por: Dong, Xian-Zhe, et al.
Publicado: (2016)

Jia-Wei-Kai-Xin-San Treatment Alleviated Mild Cognitive Impairment through Anti-Inflammatory and Antiapoptotic Mechanisms in SAMP8 Mice
por: Zhang, Xiaolu, et al.
Publicado: (2023)

In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L
por: Cai, Chuipu, et al.
Publicado: (2021)

Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation
por: Jia, Li-ying, et al.
Publicado: (2021)

Kai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus
por: Zhu, Yue, et al.
Publicado: (2017)

A Chinese herbal decoction, reformulated from Kai-Xin-San, relieves the depression-like symptoms in stressed rats and induces neurogenesis in cultured neurons
por: Yan, Lu, et al.
Publicado: (2016)

Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice
por: Lyu, Wenjiao, et al.
Publicado: (2021)

San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review
por: Wu, Jiasi, et al.
Publicado: (2016)

Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus
por: Xu, Lvjie, et al.
Publicado: (2023)

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease
por: Dai, Zhao, et al.
Publicado: (2022)

A Network Pharmacology Study of the Multi-Targeting Profile of an Antiarrhythmic Chinese Medicine Xin Su Ning
por: Wang, Taiyi, et al.
Publicado: (2019)

Network Pharmacology-Based Approach Uncovers the Mechanism of GuanXinNing Tablet for Treating Thrombus by MAPKs Signal Pathway
por: Wang, Mu-Lan, et al.
Publicado: (2020)

A Standardized Chinese Herbal Decoction, Kai-Xin-San, Restores Decreased Levels of Neurotransmitters and Neurotrophic Factors in the Brain of Chronic Stress-Induced Depressive Rats
por: Zhu, Kevin Yue, et al.
Publicado: (2012)

Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders
por: Fang, Jiansong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a15s5b1e8gpv9kajtdolqbj2vl